InvestorsHub Logo
Followers 618
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: Ubertino post# 4910

Monday, 06/22/2015 10:28:40 PM

Monday, June 22, 2015 10:28:40 PM

Post# of 6723
I don't agree. TKM-ebola did very well in the primate studies. The focus on HBV is simply due to more money coming in with an approved drug in that arena.

You'll notice, Tekmira never played up the Ebola card like other companies did.












To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News